nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant activity of interferon alpha: mechanism(s) of action
|
Tovey, Michael G. |
|
2006 |
24 |
S2 |
p. S46-S47 2 p. |
artikel |
2 |
Adjuvant properties of lipopolysaccharide from Neisseria meningitidis serogroup B detoxified and conjugated with tetanus toxoid
|
Balboa, Julio A. |
|
2006 |
24 |
S2 |
p. S63-S64 2 p. |
artikel |
3 |
Adjuvants: Present regulatory challenges
|
Pascual, Danay Mora |
|
2006 |
24 |
S2 |
p. S88-S89 2 p. |
artikel |
4 |
A novel adjuvant complex, tyrosine-MPL, for prophylactic and therapeutic vaccines
|
Wheeler, Alan |
|
2006 |
24 |
S2 |
p. S40-S41 2 p. |
artikel |
5 |
Antibodies against cell surface antigens as very potent immunological adjuvants
|
Barr, Tom |
|
2006 |
24 |
S2 |
p. S20-S21 2 p. |
artikel |
6 |
Attenuated Bordetella pertussis: new live vaccines for intranasal immunisation
|
Mielcarek, Nathalie |
|
2006 |
24 |
S2 |
p. S54-S55 2 p. |
artikel |
7 |
Bacterial derived proteoliposome as ideal delivery system and cellular adjuvant
|
Rodríguez, Tamara |
|
2006 |
24 |
S2 |
p. S24-S25 2 p. |
artikel |
8 |
Bacterial derived proteoliposome for allergy vaccines
|
Lastre, Miriam |
|
2006 |
24 |
S2 |
p. S34-S35 2 p. |
artikel |
9 |
Comparative study of the immunogenicity and immunoenhancing effects of two hepatitis B core antigen variants in mice by nasal administration
|
Lobaina, Y. |
|
2006 |
24 |
S2 |
p. S58-S59 2 p. |
artikel |
10 |
CpG oligodeoxynucleotides and mobilization of innate mucosal immunity: tasks and tactics
|
Harandi, Ali M. |
|
2006 |
24 |
S2 |
p. S48-S49 2 p. |
artikel |
11 |
Editorial Board/Aims and Scope
|
|
|
2006 |
24 |
S2 |
p. CO2- 1 p. |
artikel |
12 |
High-performance reverse phase chromatography with fluorescence detection assay for characterization and quantification of pneumococcal polysaccharides
|
Canaán-Haden, Leonardo |
|
2006 |
24 |
S2 |
p. S70-S71 2 p. |
artikel |
13 |
How bacteria and their products provide clues to vaccine and adjuvant development
|
Dougan, Gordon |
|
2006 |
24 |
S2 |
p. S13-S19 7 p. |
artikel |
14 |
IFN-α/β-dependent cross-priming induced by specific toll-like receptor agonists
|
Durand, Vanessa |
|
2006 |
24 |
S2 |
p. S22-S23 2 p. |
artikel |
15 |
Immunological evaluation of bacterial derived Cochleate and Proteoliposome as mucosal adjuvants
|
del Campo, Judith |
|
2006 |
24 |
S2 |
p. S50-S51 2 p. |
artikel |
16 |
Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults
|
Black, Steven |
|
2006 |
24 |
S2 |
p. S79-S80 2 p. |
artikel |
17 |
Invitation to next meeting
|
|
|
2006 |
24 |
S2 |
p. III- 1 p. |
artikel |
18 |
Liposomal preparations of muramyl glycopeptides as immunomodulators and adjuvants
|
Turánek, Jaroslav |
|
2006 |
24 |
S2 |
p. S90-S91 2 p. |
artikel |
19 |
Modulation of the specific allergic response by mite allergens encapsulated into liposomes
|
Calderón, Lesly |
|
2006 |
24 |
S2 |
p. S38-S39 2 p. |
artikel |
20 |
Mucosal immune responses to meningococcal C polysaccharide–protein conjugate in mice
|
Cuello, Maribel |
|
2006 |
24 |
S2 |
p. S72-S73 2 p. |
artikel |
21 |
2nd International Workshop on Vaccine Adjuvants and Glycoconjugates, Varadero, Cuba, 11–15 April 2004
|
Pérez, Oliver |
|
2006 |
24 |
S2 |
p. S1-S2 2 p. |
artikel |
22 |
New method for obtaining conjugated vaccines
|
Cabrera, Osmir |
|
2006 |
24 |
S2 |
p. S76-S78 3 p. |
artikel |
23 |
Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity
|
Petrovsky, Nikolai |
|
2006 |
24 |
S2 |
p. S26-S29 4 p. |
artikel |
24 |
On the cross-fertilization between biotechnology and immunology: current situation in Cuba
|
Lage, Agustin |
|
2006 |
24 |
S2 |
p. S3-S6 4 p. |
artikel |
25 |
Poster abstract
|
|
|
2006 |
24 |
S2 |
p. S96-S102 7 p. |
artikel |
26 |
Preparation and evaluation of Vibrio cholerae O1 EL Tor Ogawa lipopolysaccharide–tetanus toxoid conjugates
|
Cabrera, Osmir |
|
2006 |
24 |
S2 |
p. S74-S75 2 p. |
artikel |
27 |
Proteliposome-derived Cochleate as an immunomodulator for nasal vaccine
|
Pérez, Oliver |
|
2006 |
24 |
S2 |
p. S52-S53 2 p. |
artikel |
28 |
Proteoliposome derived cochleate as novel adjuvant
|
Bracho, Gustavo |
|
2006 |
24 |
S2 |
p. S30-S31 2 p. |
artikel |
29 |
Regulatory considerations on new adjuvants and delivery systems
|
Sesardic, D. |
|
2006 |
24 |
S2 |
p. S86-S87 2 p. |
artikel |
30 |
Reverse vaccinology — In search of a genome-derived meningococcal vaccine
|
Danzig, Lisa |
|
2006 |
24 |
S2 |
p. S11-S12 2 p. |
artikel |
31 |
Scale up of proteoliposome derived Cochleate production
|
Zayas, Caridad |
|
2006 |
24 |
S2 |
p. S94-S95 2 p. |
artikel |
32 |
State of the art in developing allergen vaccines in Cuba: prospects of novel adjuvanted vaccines
|
Labrada, Alexis |
|
2006 |
24 |
S2 |
p. S36-S37 2 p. |
artikel |
33 |
Strategy for determination of an efficient Cochleate particle size
|
Gil, Danay |
|
2006 |
24 |
S2 |
p. S92-S93 2 p. |
artikel |
34 |
Sucrose fatty acid sulphate esters as novel vaccine adjuvant
|
Hilgers, Luuk A.Th. |
|
2006 |
24 |
S2 |
p. S81-S82 2 p. |
artikel |
35 |
Surfactants in vaccine adjuvants: description and perspectives
|
Ascarateil, Stephane |
|
2006 |
24 |
S2 |
p. S83-S85 3 p. |
artikel |
36 |
The adjuvant potential of synthetic alkylglycerols
|
Acevedo, Reinaldo |
|
2006 |
24 |
S2 |
p. S32-S33 2 p. |
artikel |
37 |
The use of oil adjuvants in therapeutic vaccines
|
Aucouturier, Jerome |
|
2006 |
24 |
S2 |
p. S44-S45 2 p. |
artikel |
38 |
The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery
|
Davis, Stanley S. |
|
2006 |
24 |
S2 |
p. S7-S10 4 p. |
artikel |
39 |
Transepithelial immunomodulation by cholera toxin and non-toxic derivatives
|
Anjuère, Fabienne |
|
2006 |
24 |
S2 |
p. S62- 1 p. |
artikel |
40 |
Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus
|
Bracci, Laura |
|
2006 |
24 |
S2 |
p. S56-S57 2 p. |
artikel |
41 |
Use of a conjugate polysaccharide vaccine in the prevention of invasive staphylococcal disease: Is an additional vaccine needed or possible?
|
Shinefield, Henry R. |
|
2006 |
24 |
S2 |
p. S65-S69 5 p. |
artikel |
42 |
Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for dendritic cell activation
|
Mesa, Circe |
|
2006 |
24 |
S2 |
p. S42-S43 2 p. |
artikel |
43 |
Zonula occludens toxin as a new promising adjuvant for mucosal vaccines
|
Magistris, Maria Teresa De |
|
2006 |
24 |
S2 |
p. S60-S61 2 p. |
artikel |